|
End-of-day quote
LUXEMBOURG S.E.
18/09/2026
|
5-day change | 1st Jan Change | ||
| 40.20 USD | -1.47% |
|
+0.50% | +33.11% |
| 18/09 | EU Medicines Agency Panel Issues Positive Opinion on Gedeon Richter's Arthritis Drug | MT |
| 12/08 | Gedeon Richter PLC, Q2 2026 Earnings Call, Aug 07, 2026 |
Company Valuation: Gedeon Richter
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,619,625 | 1,542,290 | 1,627,029 | 1,893,161 | 1,799,226 | 2,340,071 | - | - |
| Change | - | -4.77% | 5.49% | 16.36% | -4.96% | 30.06% | - | - |
| Enterprise Value (EV) 1 | 1,559,769 | 1,395,557 | 1,546,536 | 1,782,343 | 1,588,618 | 2,077,595 | 1,930,059 | 1,803,091 |
| Change | - | -10.53% | 10.82% | 15.25% | -10.87% | 30.78% | -7.1% | -6.58% |
| P/E | 11.6x | 9.94x | 10.2x | 7.96x | 7.76x | 9.44x | 8.07x | 7.47x |
| PBR | 1.78x | 1.47x | 1.44x | 1.49x | 1.31x | 1.56x | 1.41x | 1.28x |
| PEG | - | 0.9x | 3.41x | 0.2x | -2.82x | 1.36x | 0.5x | 0.93x |
| Capitalization / Revenue | 2.57x | 1.92x | 2.02x | 2.21x | 1.94x | 2.46x | 2.29x | 2.14x |
| EV / Revenue | 2.47x | 1.74x | 1.92x | 2.08x | 1.71x | 2.18x | 1.89x | 1.65x |
| EV / EBITDA | 8.86x | 7.1x | 6.43x | 5.74x | 4.5x | 5.65x | 4.87x | 4.24x |
| EV / EBIT | 11.5x | 9.09x | 8.15x | 6.82x | 5.42x | 6.87x | 5.8x | 5.02x |
| EV / FCF | -460x | 12.3x | 17.9x | 8.26x | 7.56x | 9.2x | 8.18x | 7.01x |
| FCF Yield | -0.22% | 8.12% | 5.6% | 12.1% | 13.2% | 10.9% | 12.2% | 14.3% |
| Dividend per Share 2 | 225 | 390 | - | - | - | 603.6 | 677 | 738.7 |
| Rate of return | 2.58% | 4.7% | - | - | - | 4.7% | 5.28% | 5.76% |
| EPS 2 | 751 | 835 | 860 | 1,307 | 1,271 | 1,359 | 1,589 | 1,718 |
| Distribution rate | 30% | 46.7% | - | - | - | 44.4% | 42.6% | 43% |
| Net sales 1 | 630,595 | 802,755 | 805,158 | 857,545 | 928,962 | 951,368 | 1,020,834 | 1,093,689 |
| EBITDA 1 | 176,123 | 196,480 | 240,625 | 310,678 | 353,314 | 367,576 | 396,366 | 425,015 |
| EBIT 1 | 135,832 | 153,555 | 189,817 | 261,157 | 292,851 | 302,220 | 332,887 | 359,032 |
| Net income 1 | 139,626 | 155,581 | 158,850 | 239,244 | 232,335 | 254,304 | 290,549 | 314,929 |
| Net Debt 1 | -59,856 | -146,733 | -80,493 | -110,818 | -210,608 | -262,476 | -410,012 | -536,980 |
| Reference price 2 | 8,725.00 | 8,300.00 | 8,750.00 | 10,400.00 | 9,865.00 | 12,830.00 | 12,830.00 | 12,830.00 |
| Nbr of stocks (in thousands) | 185,630 | 185,818 | 185,946 | 182,035 | 182,385 | 182,391 | - | - |
| Announcement Date | 2/3/22 | 28/2/23 | 29/2/24 | 7/4/25 | 27/2/26 | - | - | - |
1HUF in Million2HUF
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 33.9x | 6.35x | 22.04x | 0.93% | 45.94B | |
| 15.94x | 1.97x | 8.74x | 1.66% | 37.22B | |
| 27.81x | 3.97x | 16.44x | 0.58% | 12.06B | |
| 27.15x | 3.29x | 17.06x | 0.93% | 11.74B | |
| 18.58x | 3.37x | 11.75x | 3.79% | 9.03B | |
| 9.44x | 2.18x | 5.65x | 4.7% | 7.36B | |
| 15.18x | 2.01x | 6.67x | 3.28% | 7.15B | |
| 29.77x | 3.9x | 18.12x | 0.16% | 7.2B | |
| Average | 22.22x | 3.38x | 13.31x | 2% | 17.21B | |
| Weighted average by Cap. | 24.44x | 3.93x | 14.98x | 1.57% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- RICHTER Stock
- CHWGR Stock
- Valuation Gedeon Richter
Select your edition
All financial news and data tailored to specific country editions
